These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7045599)

  • 1. Erythrocyte - endothelial cell adherence in sickle cell disease, diabetes mellitus, and falciparum malaria: adverse effects reversed with piracetam.
    Nalbandian RM; Henry RL; Fleischman JA; Burek L; Williams G; O'Donnell FE; Diglio CA; Collier BD; Reeser FH
    Med Hypotheses; 1982 Feb; 8(2):155-62. PubMed ID: 7045599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of piracetam on sickle erythrocytes and sickle hemoglobin.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Devlin MT; Schwartz E
    Biochim Biophys Acta; 1981 May; 668(3):397-405. PubMed ID: 7236716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of piracetam and iodoacetamide on erythrocyte sickling.
    Costa FF; Zago MA; Bottura C
    Lancet; 1979 Dec; 2(8155):1302. PubMed ID: 93216
    [No Abstract]   [Full Text] [Related]  

  • 4. Diminished adherence of sickle erythrocytes to cultured vascular endothelium by piracetam.
    Nalbandian RM; Henry RL; Burek CL; Diglio CA; Goldman AI; Taylor GW; Hoffman WH
    Am J Hematol; 1983 Sep; 15(2):147-51. PubMed ID: 6613985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of piracetam improves sickle cell deformability in vitro and in vivo.
    Gini EK; Sonnet J
    J Clin Pathol; 1987 Jan; 40(1):99-102. PubMed ID: 3818978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piracetam and acetamide in sickle-cell disease.
    de Araujo JT; Nero GS
    Lancet; 1977 Aug; 2(8034):411. PubMed ID: 70630
    [No Abstract]   [Full Text] [Related]  

  • 7. [Erythrocyte adhesion to vascular endothelium: clinical applications].
    Chaudet B; Renard M; Seigneur M; Boisseau MR
    Rev Med Interne; 2000 Jul; 21(7):599-607. PubMed ID: 10942976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trial prevention of vaso-occlusive crises in homozygote sickle cell anemia using piracetam].
    Sonnet J; Gini EK; Cornu G
    Ann Soc Belg Med Trop; 1985; 65(1):77-84. PubMed ID: 4004377
    [No Abstract]   [Full Text] [Related]  

  • 9. Adhesion of erythrocytes to endothelium in pathological situations: a review article.
    Chappey O; Wautier-Pepin MP; Wautier JL
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):281-8. PubMed ID: 7971246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piracetam in sickle-cell anaemia.
    de Melo GO
    Lancet; 1976 Nov; 2(7995):1139-40. PubMed ID: 62977
    [No Abstract]   [Full Text] [Related]  

  • 11. Sickle-cell disease: Two new therapeutic strategies.
    Nalbandian RM; Henry RL; Murayama M
    Lancet; 1978 Sep; 2(8089):570-1. PubMed ID: 79930
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative study of the adhesion of sickle cells and malarial-parasitized red cells to cultured endothelium.
    Rowland PG; Nash GB; Cooke BM; Stuart J
    J Lab Clin Med; 1993 May; 121(5):706-13. PubMed ID: 8478598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erythrocyte adhesion to the vascular endothelium].
    Wautier JL; Wautier MP
    Transfus Clin Biol; 1999 Dec; 6(6):397-402. PubMed ID: 10666797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of erythrocyte adhesion to endothelial cells in diseases.
    Wautier JL; Wautier MP
    Clin Hemorheol Microcirc; 2013; 53(1-2):11-21. PubMed ID: 22941965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piracetam is useful in the treatment of children with sickle cell disease.
    el-Hazmi MA; Warsy AS; al-Fawaz I; Opawoye AO; Taleb HA; Howsawi Z; Mohamed AA; Aly AW; Refai S; Sugathan PS; Rab AS; Ahmed HB; Abulaban M; Abdulkader AM; Farid M
    Acta Haematol; 1996; 96(4):221-6. PubMed ID: 8922488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piracetam for reducing the incidence of painful sickle cell disease crises.
    Al Hajeri AA; Fedorowicz Z; Omran A; Tadmouri GO
    Cochrane Database Syst Rev; 2007 Apr; (2):CD006111. PubMed ID: 17443614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocytes and platelet adhesion to endothelium are mediated by specialized molecules.
    Wautier JL; Wautier MP
    Clin Hemorheol Microcirc; 2004; 30(3-4):181-4. PubMed ID: 15258342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piracetam: a review of pharmacological properties and clinical uses.
    Winblad B
    CNS Drug Rev; 2005; 11(2):169-82. PubMed ID: 16007238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of membrane acting-drugs on plasmodium species and sickle cell erythrocytes.
    Ohnishi ST; Sadanaga KK; Katsuoka M; Weidanz WP
    Mol Cell Biochem; 1989 Nov 23-Dec 19; 91(1-2):159-65. PubMed ID: 2695829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piracetam and sickle-cell disease.
    Franklin IM
    Lancet; 1980 Apr; 1(8171):767-8. PubMed ID: 6103182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.